Rationale and design of the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) trial
Open Access
- 21 December 2015
- journal article
- research article
- Published by Elsevier BV in American Heart Journal
- Vol. 174, 103-110
- https://doi.org/10.1016/j.ahj.2015.12.009
Abstract
No abstract availableFunding Information
- Novo Nordisk
- Merck
- Novartis
- AstraZeneca
- Bayer
- British Microcirculation Society
This publication has 35 references indexed in Scilit:
- Effects of exenatide and liraglutide on heart rate, blood pressure and body weight: systematic review and meta-analysisBMJ Open, 2013
- Encapsulation of Exenatide in Poly-(d,l-Lactide-Co-Glycolide) Microspheres Produced an Investigational Long-Acting Once-Weekly Formulation for Type 2 DiabetesDiabetes Technology & Therapeutics, 2011
- National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participantsThe Lancet, 2011
- Cardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetesCardiovascular Diabetology, 2011
- Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific DeathThe New England Journal of Medicine, 2011
- Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trialThe Lancet, 2010
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studiesThe Lancet, 2010
- DURATION-1: Exenatide Once Weekly Produces Sustained Glycemic Control and Weight Loss Over 52 WeeksDiabetes Care, 2010
- Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4Diabetes, 2010
- Effect of renal impairment on the pharmacokinetics of exenatideBritish Journal of Clinical Pharmacology, 2007